Company Announcements

Notification of Major Holdings

Source: RNS
RNS Number : 9278V
Bank of Ireland Group PLC
12 August 2020
 

 Standard Form TR-1

  Standard form for notification of major holdings

 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the Central Bank of Ireland)

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Bank of Ireland Group PLC

2. Reason for the notification (please tick the appropriate box or boxes):

[X] An acquisition or disposal of voting rights

[ ] An acquisition or disposal of financial instruments

[ ] An event changing the breakdown of voting rights

[ ] Other (please specify):

 

3. Details of person subject to the notification obligation:

Name:

AllianceBernstein L.P.

City and country of registered office (if applicable):

New York, USA

4. Full name of shareholder(s) (if different from 3.):

5. Date on which the threshold was crossed or reached:

06 Aug 2020

6. Date on which issuer notified:

11 Aug 2020

7. Threshold(s) that is/are crossed or reached:

4%

8. Total positions of person(s) subject to the notification obligation:

 

% of voting rights attached to shares

(total of 9.A)

% of voting rights through financial instruments

(total of 9.B.1 + 9.B.2)

Total of both in %

(9.A + 9.B)

Total number of voting rights of issuer

Resulting situation on the date on which threshold was crossed or reached

4.06%

N/A

4.06%

1,078,822,872

Position of previous notification (if applicable)

3.71%

N/A

3.71%

 

 

9. Notified details of the resulting situation on the date on which the threshold was crossed or reached:

A: Voting rights attached to shares

Class/type of shares ISIN code (if possible)

Number of voting rights

% of voting rights

Direct

Indirect

Direct

Indirect

IE00BD1RP616 Common Stock

 

 43,803,414

 

 4.06%

 

 

 

 

 

SUBTOTAL A

                                43,803,414

    4.06%

 

B 1: Financial Instruments according to Regulation 17(1)(a) of the Regulations

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

 

 

 

 

 

 

SUBTOTAL B.1

 

 

 

B 2: Financial Instruments with similar economic effect according to Regulation 17(1)(b) of the Regulations

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Physical or cash settlement

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

SUBTOTAL B.2

 

 

                       

 

10. Information in relation to the person subject to the notification obligation (please tick the applicable box):

[ ] Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

[X] Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity:

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

AllianceBernstein L.P.

4.06%

 

4.06%

 

 

 

 

AllianceBernstein L.P.

4.06%

 

4.06%

AllianceBernstein Limited

 

 

 

 

 

 

 

AllianceBernstein L.P.

4.06%

 

4.06%

AllianceBernstein Japan Ltd.

 

 

 

 

 

 

 

 

11. In case of proxy voting: [name of the proxy holder] will cease to hold [% and number] voting rights as of [date].

 

12. Additional information:

 

 

Done at Dublin on 12 August 2020

Contact: Sarah McLaughlin, Group Secretary

Telephone: +353 (0) 76 624 8577

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLEANPAFSAEEEA